Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$7.87
0.020.25%
At close: -
$7.83
-0.04-0.51%
After Hours: May 16, 4:54 PM EDT
Comments
Loading...
Regulus Therapeutics Stock Price, Quotes and Forecasts
RGLSNASDAQ
Regulus Therapeutics (RGLS) Forecast
NewsEarningsRegulus Therapeutics (RGLS) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Regulus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:RGLS | Benzinga
Explore Regulus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RGLS.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Regulus Therapeutics (RGLS) stock?
You can purchase shares of Regulus Therapeutics (NASDAQ:RGLS) through any online brokerage.
Who are Regulus Therapeutics (RGLS) competitors?
Other companies in Regulus Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Cogent Biosciences (NASDAQ:COGT), Upstream Bio (NASDAQ:UPB) and Replimune Group (NASDAQ:REPL).
What is the forecast, or price target, for Regulus Therapeutics (RGLS) stock?
Regulus Therapeutics has a consensus price target of $7.71.
What is the current price for Regulus Therapeutics (RGLS)?
The stock price for Regulus Therapeutics (NASDAQ: RGLS) is $7.83 last updated May 16, 2025 at 4:54 PM EDT.
Does Regulus Therapeutics (RGLS) pay a dividend?
There are no upcoming dividends for Regulus Therapeutics.
When is Regulus Therapeutics (NASDAQ:RGLS) reporting earnings?
Regulus Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.
Is Regulus Therapeutics (RGLS) going to split?
There is no upcoming split for Regulus Therapeutics.
What sector and industry does Regulus Therapeutics (RGLS) operate in?
Regulus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
